ValiRx plc (LON:VAL – Get Free Report) shares dropped 9% on Wednesday . The company traded as low as GBX 0.13 and last traded at GBX 0.13. Approximately 2,186,069 shares traded hands during trading, a decline of 79% from the average daily volume of 10,512,327 shares. The stock had previously closed at GBX 0.14.
ValiRx Stock Performance
The firm’s fifty day moving average price is GBX 0.16 and its 200 day moving average price is GBX 0.23. The company has a current ratio of 4.62, a quick ratio of 1.27 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of £1.74 million, a price-to-earnings ratio of -0.24 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last posted its earnings results on Monday, June 22nd. The company reported GBX (0.54) earnings per share for the quarter. The company had revenue of GBX 3 million during the quarter. ValiRx had a negative net margin of 7,115.36% and a negative return on equity of 70.79%. Analysts forecast that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
